Navigation Links
Emerson Resources Expands Pharmaceutical Development and Analytical Capabilities
Date:8/13/2014

Norristown, Pennsylvania (PRWEB) August 13, 2014

Emerson Resources, Inc., a premier pharmaceutical development company, today announced the expansion of its formulation development, clinical supplies manufacturing, and analytical capabilities. The Company now offers feasibility and pilot scale spray drying for drug solubility enhancement, as well as a more robust analytical offering, via the addition of a new solid-state characterization laboratory. This growth reflects the Company’s focus on delivering pragmatic yet creative solutions to its clients, through the use of cutting-edge technologies and application of innovative problem solving.

The Company’s robust suite of pharmaceutical manufacturing equipment now features two Spray Dryers, the Buchi B290 Spray Dryer and the GEA Mobile Minor, both of which are closed-loop for organic solvents. The Mobile Minor is equipped with two-fluid and pressure nozzle spray systems to accommodate a wide range of applications.

As well as expanding its manufacturing capabilities, Emerson Resources has added a solid-state characterization laboratory to its 46,000 square foot facility, which will enable Emerson to better meet the analytical needs of its clients. The new laboratory includes a wide range of technologies such as TA Instruments Q2000 Modulated Differential Scanning Calorimeter (mDSC), JEOL Neoscope JCM-6000 Scanning Electron Microscope (SEM), Rigaku MiniFlex 600 X-Ray Diffractometer (XRD) and the Malvern Mastersizer 3000 Particle Size Analyzer (PSA).

“Drug solubility enhancement will be the key to unlocking the potential of many future therapies. Our investment in these new capabilities underscores our commitment to quickly and efficiently driving the development of these therapies,” said Rob Tuohy, Sr. Vice President & Chief Scientific Officer. “Our recent expansion, combined with our established track record of creativity, flexibility, and quality, will undoubtedly support the measurable success of our clients.”

                                                             ####

About Emerson Resources
For more than 12 years, Emerson Resources, a premier pharmaceutical development company, has delivered value-added service, ingredients and expertise to clients in the pharmaceutical and biotech industries. Emerson Resources is a leader in dosage form development, manufacturing cGMP clinical supplies, analytical method development, analytical method validation, release testing and stability testing. Based in Norristown, Pennsylvania, the Company’s expansive facility features development and analytical laboratories, a cGMP clinical supplies manufacturing plant, and a specialty ingredients excipients manufacturing center. For more information, visit http://www.emersonresources.com.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12084444.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Emerson Resources Announces CEO Retirement and Appointment of Successor
2. Cepheid Welcomes Senior Vice President of Human Resources
3. Walgreens Joins with Ferring Pharmaceuticals Inc. to Offer Products and Resources to Women Facing Fertility Complications from Cancer Treatment
4. New Informatics and Bioimaging Center combines resources, expertise from UMD, UMB
5. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
6. Wiley Job Network Announces New Resources and Tools to Connect Job Seekers and Employers
7. ClearPath Workforce Management Expert to Present on Contractor Payroll, Engagement and Compliance as Part of Institute for Human Resources Virtual Conference
8. Energy Briefing - Advancing Energy Companies Progressing This Week: Alternative Fuels Americas, Pacific Ethanol, Halcón Resources, Exxon, Kodiak Oil & Gas
9. Decision Resources Group Acquires Relay Technology Management
10. Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition
11. UV Flu Technologies Expands Its International Footprint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
Breaking Biology News(10 mins):